Literature DB >> 26405164

Role of Reference Levels in Nuclear Medicine: A Report of the SNMMI Dose Optimization Task Force.

Adam M Alessio1, Mary Beth Farrell2, Frederic H Fahey3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26405164     DOI： 10.2967/jnumed.115.160861

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  5 in total

1.  Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG.

Authors:  Wanqi Chen; Lei Liu; Yinghe Li; Shatong Li; Zhijian Li; Weiguang Zhang; Xu Zhang; Runze Wu; Debin Hu; Hongyan Sun; Yun Zhou; Wei Fan; Yumo Zhao; Yizhuo Zhang; Yingying Hu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-05       Impact factor: 10.057

2.  Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan.

Authors:  Hiroshi Watanabe; Kazunari Ishii; Makoto Hosono; Etsuko Imabayashi; Koichiro Abe; Masayuki Inubushi; Kazuko Ohno; Yasuhiro Magata; Kinya Ono; Kei Kikuchi; Kei Wagatsuma; Tadashi Takase; Kyoko Saito; Yasuyuki Takahashi
Journal:  Ann Nucl Med       Date:  2016-05-06       Impact factor: 2.668

3.  A Nordic survey of CT doses in hybrid PET/CT and SPECT/CT examinations.

Authors:  Natalie A Bebbington; Bryan T Haddock; Henrik Bertilsson; Eero Hippeläinen; Ellen M Husby; Virpi I Tunninen; Marcus Söderberg
Journal:  EJNMMI Phys       Date:  2019-12-16

4.  Investigating Low-Dose Image Quality in Whole-Body Pediatric 18F-FDG Scans Using Time-of-Flight PET/MRI.

Authors:  Jeffrey P Schmall; Suleman Surti; Hansel J Otero; Sabah Servaes; Joel S Karp; Lisa J States
Journal:  J Nucl Med       Date:  2020-06-01       Impact factor: 11.082

5.  Optimization of injection dose in 18F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan.

Authors:  Hiroaki Sagara; Kazumasa Inoue; Hideki Yaku; Amon Ohsawa; Takashi Someya; Kaori Yanagisawa; Shuhei Ohashi; Rikuta Ishigaki; Masashi Wakabayashi; Yoshihisa Muramatsu; Hirofumi Fujii
Journal:  Ann Nucl Med       Date:  2021-07-21       Impact factor: 2.668
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.